Heike Zabeck

405 total citations
12 papers, 276 citations indexed

About

Heike Zabeck is a scholar working on Pulmonary and Respiratory Medicine, Surgery and Oncology. According to data from OpenAlex, Heike Zabeck has authored 12 papers receiving a total of 276 indexed citations (citations by other indexed papers that have themselves been cited), including 8 papers in Pulmonary and Respiratory Medicine, 3 papers in Surgery and 3 papers in Oncology. Recurrent topics in Heike Zabeck's work include Lung Cancer Treatments and Mutations (5 papers), Lung Cancer Diagnosis and Treatment (4 papers) and Radiomics and Machine Learning in Medical Imaging (2 papers). Heike Zabeck is often cited by papers focused on Lung Cancer Treatments and Mutations (5 papers), Lung Cancer Diagnosis and Treatment (4 papers) and Radiomics and Machine Learning in Medical Imaging (2 papers). Heike Zabeck collaborates with scholars based in Germany, Canada and Belgium. Heike Zabeck's co-authors include Thomas Muley, Hendrik Dienemann, Henry Hoffmann, Arne Warth, Alexander H. Dalpke, Felix Lasitschka, Joachim Pfannschmidt, Michael Weitnauer, Martin Reck and Norbert Frickhofen and has published in prestigious journals such as Journal of Clinical Oncology, PLoS ONE and Annals of Oncology.

In The Last Decade

Heike Zabeck

12 papers receiving 268 citations

Peers

Heike Zabeck
Heike Zabeck
Citations per year, relative to Heike Zabeck Heike Zabeck (= 1×) peers Jun Atsumi

Countries citing papers authored by Heike Zabeck

Since Specialization
Citations

This map shows the geographic impact of Heike Zabeck's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Heike Zabeck with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Heike Zabeck more than expected).

Fields of papers citing papers by Heike Zabeck

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Heike Zabeck. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Heike Zabeck. The network helps show where Heike Zabeck may publish in the future.

Co-authorship network of co-authors of Heike Zabeck

This figure shows the co-authorship network connecting the top 25 collaborators of Heike Zabeck. A scholar is included among the top collaborators of Heike Zabeck based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Heike Zabeck. Heike Zabeck is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

12 of 12 papers shown
1.
Sørensen, Michael A., Sébastien Boutin, Marcus Mall, et al.. (2020). Pseudomonas aeruginosa Modulates the Antiviral Response of Bronchial Epithelial Cells. Frontiers in Immunology. 11. 96–96. 15 indexed citations
2.
Boulay, Karine, Matthias Groß, Maria Polycarpou‐Schwarz, et al.. (2018). Targeting LINC00673 expression triggers cellular senescence in lung cancer. RNA Biology. 15(12). 1499–1511. 28 indexed citations
3.
Zabeck, Heike, Hendrik Dienemann, Hans Hoffmann, et al.. (2018). Molecular signatures in IASLC/ATS/ERS classified growth patterns of lung adenocarcinoma. PLoS ONE. 13(10). e0206132–e0206132. 16 indexed citations
4.
Polke, Markus, Arne Warth, Claus Peter Heußel, et al.. (2018). Pulmonary Lymphangiomatosis – insights into an ultra-rare disease. PA2246–PA2246. 1 indexed citations
5.
Zhao, Jing, Julien Dinkel, Arne Warth, et al.. (2017). CT characteristics in pulmonary adenocarcinoma with epidermal growth factor receptor mutation. PLoS ONE. 12(9). e0182741–e0182741. 9 indexed citations
6.
Lasitschka, Felix, et al.. (2016). Endoplasmic Reticulum Stress Is a Danger Signal Promoting Innate Inflammatory Responses in Bronchial Epithelial Cells. Journal of Innate Immunity. 8(5). 464–478. 31 indexed citations
7.
Kreuter, Michael, Johan Vansteenkiste, Jürgen R. Fischer, et al.. (2016). Three-Year Follow-Up of a Randomized Phase II Trial on Refinement of Early-Stage NSCLC Adjuvant Chemotherapy with Cisplatin and Pemetrexed versus Cisplatin and Vinorelbine (the TREAT Study). Journal of Thoracic Oncology. 11(1). 85–93. 23 indexed citations
8.
Flechsig, Paul, Clemens Kratochwil, Lawrence H. Schwartz, et al.. (2014). Quantitative Volumetric CT-Histogram Analysis in N-Staging of 18F-FDG–Equivocal Patients with Lung Cancer. Journal of Nuclear Medicine. 55(4). 559–564. 27 indexed citations
9.
Kreuter, Michael, Johan Vansteenkiste, J.R. Fischer, et al.. (2012). Randomized phase 2 trial on refinement of early-stage NSCLC adjuvant chemotherapy with cisplatin and pemetrexed versus cisplatin and vinorelbine: the TREAT study. Annals of Oncology. 24(4). 986–992. 56 indexed citations
10.
Zabeck, Heike, Thomas Muley, Hendrik Dienemann, & Henry Hoffmann. (2011). Management of Chylothorax in Adults: When is Surgery Indicated?. The Thoracic and Cardiovascular Surgeon. 59(4). 243–246. 46 indexed citations
11.
Kreuter, Michael, Johan Vansteenkiste, J.R. Fischer, et al.. (2011). Randomized phase II trial on refinement of early-stage NSCLC adjuvant chemotherapy with cisplatin and pemetrexed (CPx) versus cisplatin and vinorelbine (CVb): TREAT.. Journal of Clinical Oncology. 29(15_suppl). 7002–7002. 3 indexed citations
12.
Pfannschmidt, Joachim, Heike Zabeck, Thomas Muley, H. Dienemann, & H. Hoffmann. (2006). Pulmonary Metastasectomy Following Chemotherapy in Patients with Testicular Tumors: Experience in 52 Patients. The Thoracic and Cardiovascular Surgeon. 54(7). 484–488. 21 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026